Skip to main content

Table 1 Level of significance of the differences (P) in SD values for the designated loci between samples of patients free of cancer (BPH) and cancer patients (CAP).

From: Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients

 

BPH SNRPN

(36.4 ± 4.7%)

BPH CEN15

(20.9 ± 5.3%)

CAP SNRPN

(24.3 ± 3.0%)

P < 10-11

P < 0.02

CAP CEN15

(37.8 ± 5.1%)

P > 0.30

P < 10-12

  1. In parentheses are the mean SD frequency (%) and the standard deviation value for the group of patients for the particular locus. Each group contained 22 cases (the compared values are presented in Figure 2).